相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anti-nociception mediated by a κ opioid receptor agonist is blocked by a δ receptor agonist
A. M. W. Taylor et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Novel orally available salvinorin A analog PR-38 protects against experimental colitis and reduces abdominal pain in mice by interaction with opioid and cannabinoid receptors
Maciej Salaga et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Michael acceptor approach to the design of new salvinorin A-based high affinity ligands for the kappa-opioid receptor
Prabhakar R. Polepally et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH)
M. Salaga et al.
JOURNAL OF CROHNS & COLITIS (2014)
Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives
Marta Sobczak et al.
JOURNAL OF GASTROENTEROLOGY (2014)
The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
Adam J. Pawson et al.
NUCLEIC ACIDS RESEARCH (2014)
Antinociceptive effects of novel melatonin receptor agonists in mouse models of abdominal pain
Chunqiu Chen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Novel Orally Available Salvinorin A Analog PR-38 Inhibits Gastrointestinal Motility and Reduces Abdominal Pain in Mouse Models Mimicking Irritable Bowel Syndrome
M. Salaga et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Kappa-opioid receptor-selective dicarboxylic ester-derived salvinorin A ligands
Prabhakar R. Polepally et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: G PROTEIN-COUPLED RECEPTORS
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Inhibition of proteases as a novel therapeutic strategy in the treatment of metabolic, inflammatory and functional diseases of the gastrointestinal tract
Maciej Salaga et al.
DRUG DISCOVERY TODAY (2013)
Investigational drugs for pruritus
Heike Benecke et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)
Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects
Katherine A. MacLean et al.
PSYCHOPHARMACOLOGY (2013)
Systemic Kappa Opioid Receptor Agonists in the Treatment of Chronic Pruritus: A Literature Review
Ngoc Quan Phan et al.
ACTA DERMATO-VENEREOLOGICA (2012)
Dose-Related Behavioral, Subjective, Endocrine, and Psychophysiological Effects of the κ Opioid Agonist Salvinorin A in Humans
Mohini Ranganathan et al.
BIOLOGICAL PSYCHIATRY (2012)
Nalfurafine hydrochloride for the treatment of pruritus
Shigeki Inui
EXPERT OPINION ON PHARMACOTHERAPY (2012)
Salvinorin A has antiinflammatory and antinociceptive effects in experimental models of colitis in mice mediated by KOR and CB1 receptors
Jakub Fichna et al.
INFLAMMATORY BOWEL DISEASES (2012)
Unidirectional Cross-Activation of GRPR by MOR1D Uncouples Itch and Analgesia Induced by Opioids
Xian-Yu Liu et al.
CELL (2011)
Automated quantitative gait analysis in animal models of movement disorders
Caroline Vandeputte et al.
BMC NEUROSCIENCE (2010)
Guidelines for reporting experiments involving animals: the ARRIVE guidelines
J. C. McGrath et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
Carol Kilkenny et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled study
Hiroo Kumagai et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
SELECTIVE NATURAL κ OPIOID AND CANNABINOID RECEPTOR AGONISTS WITH A POTENTIAL ROLE IN THE TREATMENT OF GASTROINTESTINAL DYSFUNCTION
Jakub Fichna et al.
DRUG NEWS & PERSPECTIVES (2009)
Opioids and the skin - where do we stand?
Paul L. Bigliardi et al.
EXPERIMENTAL DERMATOLOGY (2009)
Salvinorin A inhibits colonic transit and neurogenic ion transport in mice by activating κ-opioid and cannabinoid receptors
J. Fichna et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2009)
NALFURAFINE PREVENTS 5′-GUANIDINONALTRINDOLE- AND COMPOUND 48/80-INDUCED SPINAL c-fos EXPRESSION AND ATTENUATES 5′-GUANIDINONALTRINDOLE-ELICITED SCRATCHING BEHAVIOR IN MICE
S. Inan et al.
NEUROSCIENCE (2009)
Possible roles of epidermal opioid systems in pruritus of atopic dermatitis
Mitsutoshi Tominaga et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Butorphanol for treatment of intractable pruritus
AG Dawn et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
κ-opioid system in uremic pruritus:: Multicenter, randomized, double-blind, placebo-controlled clinical studies
B Wikström et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Comparison of pharmacological activities of three distinct kappa ligands (salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo
Y Wang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Kappa opioid agonists suppress chloroquine-induced scratching in mice
S Inan et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Involvement of central μ-opioid system in the scratching behavior in mice, and the suppression of it by the activation of κ-opioid system
H Umeuchi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Antipruritic activity of the κ-opioid receptor agonist, TRK-820
Y Togashi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Norbinaltorphimine, a selective κ-opioid receptor antagonist, induces an itch-associated response in mice
J Kamei et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
An experimental itch model in monkeys: Characterization of intrathecal morphine-induced scratching and antinociception
MCH Ko et al.
ANESTHESIOLOGY (2000)
分享论文
